glp 1 drugs GLP-1 Agonists: A Comprehensive Overview Do The Benefits of GLP-1

It slows digestion, promotes feelings of fullness, and enhances insulin sensitivity

(2025) Figure 2: Created in BioRender

The emerging role of glucagon-like peptide-1 receptor agonists for the treatment of metabolic dysfunction-associated steatohepatitis

Ongoing research continues to evaluate the role of these agents in populations without diabetes, particularly in the context of obesity and primary cardiovascular prevention, suggesting that their therapeutic reach may expand further in the coming years

To clarify, my understanding is that 'Meridia' (Abbott) was voluntarily withdrawn from the market rather than being banned